A Randomized, Blinded, Controlled Phase I Clinical Trial to Evaluate the Safety of a Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Adults Aged 65 Years and Older
Latest Information Update: 27 Feb 2026
At a glance
- Drugs Quadrivalent inactivated subunit adjuvanted influenza vaccine-Jiangsu Zhonghui Yuantong Biotechnology (Primary) ; MF 59
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Ab&B Biotech
Most Recent Events
- 27 Feb 2026 New trial record